Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Formycon AG. View detailed product information, certifications, and sourcing options for each API. Connect with Formycon AG for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: Germany
Supplier Description: Formycon AG is a German biopharmaceutical company headquartered in Planegg, specializing in the development of high-quality biosimilars. The company developed FYB203 (aflibercept‑mrbb), a biosimilar to Eylea®, which has received FDA approval (June 2024), European Commission approval (January 2025), and UK MHRA approval under the tradenames AHZANTIVE® and Baiama®. Formycon handles in-house API development and manufacturing, with quality data reviewed and accepted by regulators as part of their biosimilar submissions, effectively ensuring compliance with international regulatory standards.
